Evidence map›Paper›PMID 39401352›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Goblet cell differentiation subgroups in colorectal cancer.

Gulnar Abdullayeva, Haoyu Liu, Ta-Chun Liu, Alison Simmons, Marco Novelli, Irada Huseynova, Viorica L Lastun, Walter Bodmer

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. FUT2-Mediated Fucosylation of OLFM4 Promotes Colon Cancer Cell Differentiation.Canadian journal of gastroenterology & hepatology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. bioRxiv : the preprint server for biology · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gulnar AbdullayevaDepartment of Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom.
Haoyu LiuTencent Technology (Shenzhen) Co. Ltd., Shenzhen City 518000, China.
Ta-Chun LiuHayawaka Building, Oxford OX4 4GA, United Kingdom.
Alison SimmonsMedical Research Council (MRC) Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom.ORCID 0000-0003-3454-0710
Marco NovelliUniversity College London Department of Pathology, London WC1E 6HX, United Kingdom.
Irada HuseynovaInstitute of Molecular Biology and Biotechnologies, Ministry of Science and Education of the Republic of Azerbaijan, Baku AZ1073, Azerbaijan.
Viorica L LastunDepartment of Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom.
Walter BodmerDepartment of Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom.ORCID 0000-0001-6244-9792

Funding

Institute of Molecular Biology and BiotechnologiesIslamic Development Bank, Azerbaijan National Academy of SciencesMinistry of Science and Education of the Republic of Azerbaijan
6 · The paper itself

Abstract

The poor prognosis of relatively undifferentiated cancers has long been recognized, suggesting that selection against differentiation and in favor of uncontrolled growth is one of the most powerful drivers of cancer progression. Goblet cells provide the mucous surface of the gut, and when present in colorectal cancers (CRC), the cancers are called mucinous. We have used the presence of MUC2, the main mucous product of goblet cells, and an associated gene product, TFF3, to classify a large panel of nearly 80 CRC-derived cell lines into five categories based on their levels of MUC2 and TFF3 expression. We have then shown that these five patterns of expression can be easily identified in the direct analysis of tumor specimens allowing a much finer characterization of CRCs with respect to the presence of goblet cell differentiation. In particular, about 30% of all CRCs fall into the category of expressing TFF3 but not MUC2, which has not previously been acknowledged. Using the cell line data, we suggest that there are up to 12 genes (

Indexed as

Cell DifferentiationColorectal NeoplasmsGoblet CellsMucin-2Trefoil Factor-3Cell Line, TumorGene Expression Regulation, NeoplasticHumansMUC2 protein, humanMucin-2TFF3 protein, humanTrefoil Factor-3cell differentiationcolorectal cancergoblet cellsmucintrefoil factor

Identifiers

PMID39401352
PMCPMC11513979

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.